Related Experiment Video
Updated: Feb 14, 2026

09:14
Synthesis of Protein Bioconjugates via Cysteine-maleimide Chemistry
Published on: July 20, 2016
40.7K
High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based
Rachana Ohri1, Sunil Bhakta1, Aimee Fourie-O'Donohue1
1Genentech Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
Bioconjugate Chemistry
|February 10, 2018
Summary
This study identified stable antibody conjugation sites for drug delivery using THIOMAB technology. These findings enhance the development of antibody-drug conjugates with improved stability and efficacy.
Area of Science:
- Bioconjugation Chemistry
- Antibody Engineering
- Pharmacology
Background:
- THIOMAB antibody technology enables site-specific conjugation via engineered cysteines.
- Conjugation site location impacts linkage stability and antibody conjugate properties.
- Stable linkages are crucial for maximizing drug delivery to target sites.
Purpose of the Study:
- To systematically evaluate drug conjugation stabilities at all engineered cysteine positions on an anti-HER2 antibody (trastuzumab).
- To identify optimal conjugation sites for enhanced stability of antibody-drug conjugates (ADCs).
Main Methods:
- Engineered cysteine residues into every position of trastuzumab, creating 648 THIOMAB antibody variants.
- Conjugated variants to two monomethyl auristatin E (MMAE) derivatives (MC-vc-PAB-MMAE and PDS-MMAE) using high-throughput methods.
- Assessed in vitro plasma stability using ELISAs and confirmed stable sites with LC/MS.
Main Results:
- Over 50% of THIOMAB variants achieved successful conjugation with desired drug-to-antibody ratios and low aggregation.
- Identified numerous highly stable conjugation sites on both heavy and light chains for both MMAE derivatives.
- Maleimide conjugates showed greater stability than disulfide conjugates, yet stable sites were found for both types.
Conclusions:
- Highly stable conjugation sites for antibody-drug conjugates were identified across the antibody structure.
- The stability of identified sites translated across different payloads, target antibodies, and in vivo conditions.
- This systematic mapping advances the rational design of more stable and effective antibody-drug conjugates.
Related Concept Videos
Antibody Structure
65.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K
Relative Strengths of Conjugate Acid-Base Pairs
52.8K
Brønsted-Lowry acid-base chemistry is the transfer of protons; thus, logic suggests a relation between the relative strengths of conjugate acid-base pairs. The strength of an acid or base is quantified in its ionization constant, Ka or Kb, which represents the extent of the acid or base ionization reaction. For the conjugate acid-base pair HA / A−, the ionization equilibrium equations and ionization constant expressions are
52.8K
Conserved Binding Sites
5.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
Conjugated Proteins
29.2K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.2K
Conjugated Proteins
3.2K
3.2K
Cytoskeletal Linker Proteins - Plakins
2.9K
Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
2.9K

